Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$9.45 USD
-0.05 (-0.53%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $9.44 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Avid Bioservices, Inc falls in the month of April.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 0.56 | 127.67 | 11.21 | -10.47 |
Depreciation/Amortization & Depletion | NA | 8.26 | 5.51 | 4.37 | 3.09 |
Net Change from Assets/Liabilities | NA | -34.26 | -16.40 | 11.75 | 10.69 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 12.56 | -107.32 | 3.85 | 2.51 |
Net Cash From Operating Activities | NA | -12.89 | 9.47 | 31.18 | 5.83 |
Property & Equipment | NA | -77.64 | -56.41 | -9.86 | -3.81 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -77.64 | -56.41 | -9.86 | -3.81 |
Uses of Funds
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 3.41 | 3.36 | -0.93 | 1.12 |
Issuance (Repayment) of Debt | NA | -0.51 | -0.16 | 133.99 | 4.30 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | -4.46 | -4.33 |
Other Financing Activities | NA | 0.00 | 0.00 | -16.28 | 0.00 |
Net Cash from Financing Activities | NA | 2.90 | 3.20 | 112.34 | 1.10 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -87.62 | -43.75 | 133.65 | 3.11 |
Cash at Beginning of Period | NA | 126.52 | 170.27 | 36.61 | 33.50 |
Cash at End of Period | NA | 38.89 | 126.52 | 170.27 | 36.61 |
Diluted Net EPS | -2.23 | 0.01 | 1.84 | 0.06 | -0.27 |
Fiscal Year End for Avid Bioservices, Inc falls in the month of April.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -17.65 | -11.60 | -2.09 | 0.56 |
Depreciation/Amortization & Depletion | NA | 9.17 | 6.07 | 2.99 | 8.26 |
Net Change from Assets/Liabilities | NA | 14.96 | 9.47 | -2.96 | -34.26 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.22 | 1.88 | 1.79 | 12.56 |
Net Cash From Operating Activities | NA | 9.70 | 5.82 | -0.28 | -12.89 |
Property & Equipment | NA | -26.11 | -21.44 | -14.11 | -77.64 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -26.11 | -21.44 | -14.11 | -77.64 |
Uses of Funds
4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.38 | 1.00 | 0.88 | 3.41 |
Issuance (Repayment) of Debt | NA | 6.85 | 7.15 | -0.13 | -0.51 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 8.23 | 8.15 | 0.75 | 2.90 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -8.18 | -7.47 | -13.64 | -87.62 |
Cash at Beginning of Period | NA | 38.89 | 38.89 | 38.89 | 126.52 |
Cash at End of Period | NA | 30.71 | 31.42 | 25.25 | 38.89 |
Diluted Net EPS | -1.94 | -0.09 | -0.15 | -0.03 | 0.00 |